Lifecare AS Market Cap ($16.60 Million)
Market Cap & Net Worth: Lifecare AS (LIFE)
Lifecare AS market cap. Lifecare AS (OL:LIFE) has a market capitalization of $16.60 Million (Nkr157.78 Million) as of November 13, 2026. Listed on the OL stock exchange, this Norway-based company holds position #25522 globally and #238 in its home market, demonstrating a -7.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lifecare AS's stock price Nkr0.39 by its total outstanding shares 407710448 (407.71 Million). Also see cash efficiency ratio of Lifecare AS for how efficiently the company converts equity into cash flow.
Lifecare AS Market Cap History (2018–2026)
Lifecare AS market cap history from 2018 to 2026. Data shows change from $1.21 Billion to $16.60 Million (-38.66% CAGR). Check today's stock price for Lifecare AS for real-time trading data and today's change.
Lifecare AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lifecare AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Lifecare AS to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1248.78x
Lifecare AS's market cap is 1248.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.21 Billion | $3.49 Million | -$8.79 Million | 346.32x | N/A |
| 2019 | $1.56 Billion | $2.07 Million | -$6.56 Million | 752.23x | N/A |
| 2020 | $2.06 Billion | $1.67 Million | -$2.74 Million | 1229.40x | N/A |
| 2021 | $801.66 Million | $324.41K | -$15.88 Million | 2471.11x | N/A |
| 2022 | $848.81 Million | $16.71 Million | -$17.48 Million | 50.78x | N/A |
| 2023 | $2.10 Billion | $13.09 Million | -$35.26 Million | 160.72x | N/A |
| 2024 | $525.56 Million | $3.03 Million | -$71.76 Million | 173.40x | N/A |
| 2025 | $139.86 Million | $112.00K | -$119.51 Million | 1248.78x | N/A |
Competitor Companies of LIFE by Market Capitalization
Companies near Lifecare AS in the global market cap rankings as of November 13, 2026. Also see LIFE total assets for a full breakdown of the balance sheet.
Key companies related to Lifecare AS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #116 globally with a market cap of $186.49 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.82 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #224 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #238 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #116 | Abbott Laboratories | NYSE:ABT | $186.49 Billion | $107.25 |
| #204 | Stryker Corporation | NYSE:SYK | $119.82 Billion | $312.39 |
| #224 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $100.99 |
| #238 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Lifecare AS (2018–2026)
Market capitalization of Lifecare AS from 2018 to today. Between 2018 and today, Lifecare AS's market cap moved from $1.21 Billion to $ 16.60 Million, with a yearly change of -38.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr16.60 Million | -88.13% |
| 2025 | Nkr139.86 Million | -73.39% |
| 2024 | Nkr525.56 Million | -75.01% |
| 2023 | Nkr2.10 Billion | +147.78% |
| 2022 | Nkr848.81 Million | +5.88% |
| 2021 | Nkr801.66 Million | -61.01% |
| 2020 | Nkr2.06 Billion | +32.12% |
| 2019 | Nkr1.56 Billion | +28.91% |
| 2018 | Nkr1.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 13th, 2026 the market cap of Lifecare AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.60 Million USD |
| MoneyControl | $16.60 Million USD |
| MarketWatch | $16.60 Million USD |
| marketcap.company | $16.60 Million USD |
| Reuters | $16.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more